| Breakdown | TTM | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 147.54B | 156.61B | 155.38B | 154.46B | 140.38B | 134.08B |
| Gross Profit | 79.81B | 80.36B | 81.13B | 81.08B | 72.45B | 59.31B |
| EBITDA | 6.19B | 5.33B | 5.41B | 6.26B | 8.88B | -7.00B |
| Net Income | 17.33B | 15.23B | 4.85B | 3.06B | 1.02B | 3.86B |
Balance Sheet | ||||||
| Total Assets | 122.70B | 141.16B | 133.46B | 135.43B | 140.44B | 154.95B |
| Cash, Cash Equivalents and Short-Term Investments | 28.90B | 46.33B | 27.47B | 32.20B | 40.23B | 49.87B |
| Total Debt | 9.08B | 1.66B | 9.96B | 9.77B | 16.18B | 25.20B |
| Total Liabilities | 29.94B | 32.92B | 36.04B | 36.55B | 42.70B | 57.52B |
| Stockholders Equity | 92.49B | 107.91B | 97.08B | 98.48B | 97.21B | 96.98B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.28B | -2.85B | -1.15B | 257.00M | -8.23B |
| Operating Cash Flow | 0.00 | 5.72B | -525.00M | 1.33B | 1.38B | -5.30B |
| Investing Cash Flow | 0.00 | 28.33B | 3.50B | -110.00M | -3.98B | 36.01B |
| Financing Cash Flow | 0.00 | -15.13B | -7.25B | -9.59B | -8.96B | -11.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥136.87B | 14.56 | 11.70% | 3.59% | 3.96% | -36.24% | |
71 Outperform | ¥21.19B | 5.55 | ― | 1.83% | 7.83% | 108.92% | |
68 Neutral | ¥54.33B | 7.26 | 18.28% | 6.12% | -6.22% | 679.61% | |
66 Neutral | ¥117.21B | 17.53 | 2.80% | 3.38% | >-0.01% | -49.83% | |
66 Neutral | ¥42.84B | 13.45 | ― | 5.23% | ― | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥228.81B | 39.72 | 5.31% | 2.29% | -6.04% | 146.54% |